148 related articles for article (PubMed ID: 16081631)
1. A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1/2 signaling pathway.
Jabbour HN; Sales KJ; Boddy SC; Anderson RA; Williams AR
Endocrinology; 2005 Nov; 146(11):4657-64. PubMed ID: 16081631
[TBL] [Abstract][Full Text] [Related]
2. F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Williams AR; Anderson RA; Jabbour HN
Endocrinology; 2007 Aug; 148(8):3635-44. PubMed ID: 17478553
[TBL] [Abstract][Full Text] [Related]
3. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.
Keightley MC; Sales KJ; Jabbour HN
BMC Cancer; 2010 Sep; 10():488. PubMed ID: 20840749
[TBL] [Abstract][Full Text] [Related]
4. A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas.
Sales KJ; List T; Boddy SC; Williams AR; Anderson RA; Naor Z; Jabbour HN
Cancer Res; 2005 Sep; 65(17):7707-16. PubMed ID: 16140938
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma.
Wallace AE; Sales KJ; Catalano RD; Anderson RA; Williams AR; Wilson MR; Schwarze J; Wang H; Rossi AG; Jabbour HN
Cancer Res; 2009 Jul; 69(14):5726-33. PubMed ID: 19549892
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element.
Sales KJ; Grant V; Jabbour HN
Mol Cell Endocrinol; 2008 Mar; 285(1-2):51-61. PubMed ID: 18316157
[TBL] [Abstract][Full Text] [Related]
7. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways.
Sales KJ; Milne SA; Williams AR; Anderson RA; Jabbour HN
J Clin Endocrinol Metab; 2004 Feb; 89(2):986-93. PubMed ID: 14764825
[TBL] [Abstract][Full Text] [Related]
8. Novel suppression mechanism operating in early phase of adipogenesis by positive feedback loop for enhancement of cyclooxygenase-2 expression through prostaglandin F2α receptor mediated activation of MEK/ERK-CREB cascade.
Ueno T; Fujimori K
FEBS J; 2011 Aug; 278(16):2901-12. PubMed ID: 21668646
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin (PG) F(2alpha) receptor expression and signaling in human endometrium: role of PGF(2alpha) in epithelial cell proliferation.
Milne SA; Jabbour HN
J Clin Endocrinol Metab; 2003 Apr; 88(4):1825-32. PubMed ID: 12679480
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1.
Sales KJ; Grant V; Cook IH; Maldonado-Pérez D; Anderson RA; Williams AR; Jabbour HN
Am J Pathol; 2010 Jan; 176(1):435-45. PubMed ID: 20008143
[TBL] [Abstract][Full Text] [Related]
11. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways.
Sales KJ; Maudsley S; Jabbour HN
Mol Endocrinol; 2004 Jun; 18(6):1533-45. PubMed ID: 15044590
[TBL] [Abstract][Full Text] [Related]
12. F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2.
Keightley MC; Brown P; Jabbour HN; Sales KJ
BMC Cell Biol; 2010 Jan; 11():8. PubMed ID: 20092633
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.
Sales KJ; Maldonado-Pérez D; Grant V; Catalano RD; Wilson MR; Brown P; Williams AR; Anderson RA; Thompson EA; Jabbour HN
Biochim Biophys Acta; 2009 Dec; 1793(12):1917-28. PubMed ID: 19819266
[TBL] [Abstract][Full Text] [Related]
14. Chemokine (C-C) motif ligand 20 is regulated by PGF(2α)-F-prostanoid receptor signalling in endometrial adenocarcinoma and promotes cell proliferation.
Wallace AE; Catalano RD; Anderson RA; Jabbour HN
Mol Cell Endocrinol; 2011 Jan; 331(1):129-35. PubMed ID: 20816914
[TBL] [Abstract][Full Text] [Related]
15. Cross talk between PKC and CREB in the induction of COX-2 by PGF2α in human amnion fibroblasts.
Guo CM; Kasaraneni N; Sun K; Myatt L
Endocrinology; 2012 Oct; 153(10):4938-45. PubMed ID: 22919060
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms by which oxytocin mediates ovine endometrial prostaglandin F2alpha synthesis: role of G(i) proteins and mitogen-activated protein kinases.
Burns PD; Mendes JO; Yemm RS; Clay CM; Nelson SE; Hayes SH; Silvia WJ
Biol Reprod; 2001 Oct; 65(4):1150-5. PubMed ID: 11566737
[TBL] [Abstract][Full Text] [Related]
17. Biasing the prostaglandin F2α receptor responses toward EGFR-dependent transactivation of MAPK.
Goupil E; Wisehart V; Khoury E; Zimmerman B; Jaffal S; Hébert TE; Laporte SA
Mol Endocrinol; 2012 Jul; 26(7):1189-202. PubMed ID: 22638073
[TBL] [Abstract][Full Text] [Related]
18. Protection of 6-OHDA neurotoxicity by PGF
Sano A; Maehara T; Fujimori K
Toxicology; 2021 Feb; 450():152686. PubMed ID: 33486071
[TBL] [Abstract][Full Text] [Related]
19. F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells.
Sales KJ; Boddy SC; Jabbour HN
Oncogene; 2008 Apr; 27(17):2466-77. PubMed ID: 17968320
[TBL] [Abstract][Full Text] [Related]
20. Augmented Angiogenic Factors Expression via FP Signaling Pathways in Peritoneal Endometriosis.
Rakhila H; Al-Akoum M; Doillon C; Lacroix-Pépin N; Leboeuf M; Lemyre M; Akoum A; Pouliot M
J Clin Endocrinol Metab; 2016 Dec; 101(12):4752-4763. PubMed ID: 27726474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
